Abstract

We have adapted Tip-Enhanced Raman Spectroscopy (TERS) technology to a DNA sequencing modality simultaneously sensitive to a broad spectrum of cancer-relevant lesions. Obstacles encountered while approaching single-base resolution will be discussed.

© 2011 OSA

PDF Article